Russia Implants Prosthesis Directly into Bone Tissue for First Time

Photo Source: Freepik/ pch.vector

Osseointegrated exoprosthesis is indicated for patients experiencing problems with traditional prostheses. For example, when prosthetic sockets are ineffective, with soft tissue defects, chronic dermatological conditions of the stump, or individual anatomical limitations. Unlike traditional socket exoprostheses, load is transmitted not through soft tissues but directly through bone.

This prosthetic technique has gained widespread adoption globally: it received FDA approval in the USA in 2015, and to date over 10,000 patients in various countries have undergone this procedure.

The surgery in Russia was performed within the clinical testing protocol for new treatment methods, a special Ministry of Health program for implementing and verifying the effectiveness of novel medical technologies. Testing provides opportunities not only to cover patient medical care at state expense but also to replicate the technology, refine approaches to preventing potential complications, and eliminate barriers to its widespread implementation.

The entire complex of work was implemented on a fully domestic technological platform, from engineering development and implant production (managed by Motorika company) to surgical procedure and subsequent patient prosthetics and rehabilitation.

Exoprosthesis through bone tissue is a promising direction in traumatology and orthopedics, but requires high-quality clinical infrastructure, highly skilled surgeons, well-organized rehabilitation, and risk prevention such as infectious complications.

The need for prosthetics is growing worldwide – not only due to trauma but also due to rising rates of obesity, diabetes, and vascular diseases.

Previously, Marus Media reported on the launch of a prosthetist training program in the country, as well as the development of the innovative Omni Hand prosthesis capable of recognizing "phantom" human gestures.

Source: TASS